Correlation Between Cingulate Warrants and Vir Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Vir Biotechnology, you can compare the effects of market volatilities on Cingulate Warrants and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Vir Biotechnology.

Diversification Opportunities for Cingulate Warrants and Vir Biotechnology

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cingulate and Vir is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Vir Biotechnology go up and down completely randomly.

Pair Corralation between Cingulate Warrants and Vir Biotechnology

Assuming the 90 days horizon Cingulate Warrants is expected to generate 1.69 times less return on investment than Vir Biotechnology. In addition to that, Cingulate Warrants is 3.17 times more volatile than Vir Biotechnology. It trades about 0.0 of its total potential returns per unit of risk. Vir Biotechnology is currently generating about 0.02 per unit of volatility. If you would invest  786.00  in Vir Biotechnology on September 12, 2024 and sell it today you would lose (4.00) from holding Vir Biotechnology or give up 0.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.44%
ValuesDaily Returns

Cingulate Warrants  vs.  Vir Biotechnology

 Performance 
       Timeline  
Cingulate Warrants 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable technical and fundamental indicators, Cingulate Warrants is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Vir Biotechnology 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Vir Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady forward indicators, Vir Biotechnology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Cingulate Warrants and Vir Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cingulate Warrants and Vir Biotechnology

The main advantage of trading using opposite Cingulate Warrants and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.
The idea behind Cingulate Warrants and Vir Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing